Dr Gil Morgan from OncoAlert gives his oncology highlights from social media from day 2 of ASCO 2021.

Alerts cover trials such as OlympiA, PALOMA-3, PACIFIC, KEYNOTE-811, and Checkmate 649.

Dr Morgan also tells everybody not to miss the KEYNOTE-564 presentation by Dr Toni Choueiri talking about pembro vs placebo as post-nephrectomy adjuvant therapy.

You can watch Dr Morgan's previous roundup here

Follow Dr Morgan on twitter: @OncoAlert

Follow ecancer on twitter: @ecancer